Viruses that infect bacteria, known as bacteriophages, may have evolved some of the most precise gene-editing machinery in nature, according to new research from the University of Chicago. The study, published in Molecular Cell, shows how a class of enzymes called large serine integrases can insert large stretches of viral DNA into a host bacterium's genome — and then reverse the process without leaving a trace.
For scientists working on genome engineering, the finding is significant because current tools often rely on cutting DNA and letting the cell's own repair machinery patch the break, which can introduce errors. The integrases studied here accomplish the same insertion and removal without ever nicking the host DNA, according to the university's news release.
"One of the nice advantages of these enzymes for genome editing is that they leave no DNA damage. When they work like they're supposed to, they don't even leave a single nicked bond in the host DNA," said Phoebe Rice, professor of biochemistry and molecular biology at UChicago and senior author of the study.
A long-standing puzzle has been how these enzymes control directionality — whether they are inserting viral DNA into the host chromosome or removing it. In nature, an integrase first inserts viral DNA in one direction. To reverse the process, the enzyme needs help from a partner protein called a recombination directionality factor (RDF). Scientists knew this behaviour existed but lacked the structural detail to explain how the molecular switch worked.
To solve the problem, Rice and her colleagues used cryo-electron microscopy, a technique that rapidly freezes biological molecules and images them with an electron beam to produce near-atomic-resolution 3D structures. The team captured multiple stages of both DNA insertion and removal.
The structures revealed that part of the integrase acts like a movable arm that locks newly inserted phage DNA into place. When it is time to remove the phage DNA, the RDF changes the enzyme into a different shape. In other words, the enzyme uses two distinct processes depending on whether it is inserting or removing DNA.
"The protein can assume a different shape when it's bound to the product, which traps it that way," Rice said. "But these phages can also pop back out of the host. So, they make a second protein that binds to the integrase protein, changes its shape again, and then the reverse reaction happens."
Beyond answering a fundamental biological question, the work has practical implications. Large serine integrases are already being explored as tools for genome editing and programmable genetic switches. Rice's lab has been collaborating with UChicago chemistry associate professor Weixin Tang on using these enzymes for genome editing in mammalian cells.
By revealing which parts of the proteins control activity and directionality, the study offers a roadmap for engineering improved versions tailored for biotechnology and medicine. For university students interested in careers in genetics, synthetic biology, or biomedical engineering, this research points toward a new class of editing tools that could be safer and more precise than current methods.
The study, titled "Structural basis of directionality control in large serine integrases," was supported by the National Science Foundation, UK Research and Innovation, and the Wellcome Trust. Additional authors include researchers from UChicago and Liverpool John Moores University in the UK.